Position in NBIX
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$3,707
+$1,468 QoQ
Shares Held
22
+29.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#716
of 768 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MV CAPITAL MANAGEMENT, INC. holds $94,890 across 10 Drug Manufacturers - Specialty & Generic names. NBIX ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
663 | $47,643 | |
| 2 | VTRS |
Viatris Inc
|
1,074 | $17,055 | |
| 3 | HLN |
Haleon plc
|
992 | $9,255 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
290 | $7,136 | |
| 5 | PRGO |
PERRIGO Co plc
|
412 | $4,280 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
This page
|
22 | $3,707 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
179 | $2,869 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
13 | $1,442 |
All Filings in NBIX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,707 | 22 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $2,239 | 17 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $2,411 | 17 | Shares | Sole | 2026-02-23 | |
| 2025-09-30 | $2,386 | 17 | Shares | Sole | 2026-02-23 | |
| 2025-06-30 | $2,136 | 17 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,327 | 12 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $2,184 | 16 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,152 | 10 | Shares | Sole | 2024-11-04 | |
| No filing history on record for this holder in this stock. | ||||||